Key statistics
As of last trade, Abcellera Biologics Inc (8QQ:FRA) traded at 2.69, 58.14% above the 52 week low of 1.70 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.69 |
|---|---|
| High | 2.69 |
| Low | 2.69 |
| Bid | 2.67 |
| Offer | 2.83 |
| Previous close | 2.60 |
| Average volume | 34.28k |
|---|---|
| Shares outstanding | 299.34m |
| Free float | 230.58m |
| P/E (TTM) | -- |
| Market cap | 927.94m USD |
| EPS (TTM) | -0.5765 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 07:13 GMT.
More ▼
Press releases
- AbCellera to Present at Upcoming Investor Conferences in March and April 2026
- AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
- AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
- AbCellera and Bruker Reach Global Settlement of Patent Litigation
- AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
More ▼
